Press release
Copenhagen Airports A/S, SAS Cargo and World Courier to Host FlyPharma 2026 in Copenhagen

l-r: Michael Poulsen & Anders Furbo (World Courier), Camilla Gram (SAS Cargo) & Lars Gotfredsen (Copenhagen Airport)
FlyPharma is a leading international conference dedicated to the air transport of pharmaceutical products, bringing together airlines, airports, freight forwarders, pharmaceutical manufacturers, regulators, and logistics specialists from across the global supply chain.
Located in the heart of Medicon Valley, Copenhagen has world-class air cargo infrastructure and a reputation as a leading life sciences hub, making it an ideal setting for FlyPharma. The city is home to a dense concentration of pharmaceutical companies, cold chain logistics providers, and regulatory innovators, fostering an environment where cutting-edge temperature-controlled supply chain solutions are not just discussed but developed. Combined with Copenhagen's commitment to sustainability, streamlined port-airport connectivity, and a highly collaborative business culture, the city offers a uniquely focused and forward-looking backdrop for advancing the global pharma logistics dialogue.
There are plenty of networking opportunities, including a Pre-Conference Welcome Reception the night before the conference, and an evening Networking Event following Day 1 of conference sessions. Delegates have the opportunity to meet and connect with senior pharma and cargo professionals thus gaining new industry contacts and building on existing professional relationships.
For more information on FlyPharma Copenhagen 2026, visit https://flypharmaeurope.com/
Connectivity and Global Reach
Together, CPH and SAS Cargo provide critical connectivity between Nordic and European life science producers and global markets. FlyPharma 2026 will feature expert panels, technical sessions, and networking opportunities focused on pharmaceutical handling, compliance, cold chain innovation, and future logistics challenges.
Copenhagen Airport as a Critical Pivot in Pharma Logistics
With the rapid growth of temperature sensitive, high value, and time critical pharmaceutical products in our region, Copenhagen Airports play an increasingly vital role in orchestrate and ensuring compliance and supply chain quality. CEIV & GDP compliant handling processes, validated infrastructure, trained personnel, and close coordination between stakeholders are essential to maintaining product integrity throughout global distribution.
Hosting FlyPharma 2026 reinforces CPH's commitment to supporting the evolving needs of the pharmaceutical industry.
SAS Cargo
Markus Ek, CEO & President of SAS Cargo, stated:
"At SAS Cargo, reliability in healthcare logistics is fundamental to supporting patients and partners across the value chain. Through our IATA CEIV Pharma certification and dedicated handling processes, we work to ensure that critical shipments reach patients on time. FlyPharma 2026 offers a valuable opportunity to collaborate on the future of healthcare logistics in Copenhagen, SAS' global hub. We are pleased to co host this event to contribute to the high standards and performance the pharmaceutical industry relies on."
SAS Cargo is the leading air freight provider from Scandinavia, operating to 135 destinations across Europe, North America, and Asia, transporting more than 60,000 tons of goods annually. With a modern and fuel efficient fleet including Airbus A350 aircraft, and an extensive road feeder network, SAS Cargo is a pioneer in digitalization and holds both IATA IEnvA and CEIV Pharma certifications.
World Courier
With a global network, validated cold chain solutions, and deep clinical trial experience, World Courier plays a vital role in connecting innovative therapies with researchers, clinicians, and patients.
We ensure that critical time and temperature sensitive treatments - including advanced cell and gene therapies - move safely and reliably through the global supply chain, supported by close collaboration with airlines, airports, and partners worldwide.
By bringing our proven expertise and real world operational insight to FlyPharma 2026, World Courier aims to support the conference's mission to strengthen collaboration, share best practices, and advance the future of pharmaceutical logistics.
Medicon Valley: A Global Life Science Powerhouse
The FlyPharma Conference 2026 will take place in the heart of the Medicon Valley region, one of Europe's strongest life science clusters. The region is home to more than 1,500 life science companies and employs over 85,000 people in private life science enterprises.
In recent years, the region has seen significant growth in clinical trial activity, driven by advancements in biologics, advanced therapies, and personalized medicine-developments that place growing demands on reliable, compliant air cargo solutions. Denmark and Sweden together account for approximately 6.3% of global pharmaceutical exports, underlining their strategic importance to the international pharma supply chain.
Karl Equi, Executive Director of PMGroup Worldwide & FlyPharma commented: "We are thrilled to be bringing FlyPharma to the vibrant city of Copenhagen in 2026, placing us at the heart of the Nordic life sciences community. We look forward to partnering with our host sponsors to create a dynamic conference that explores the cutting edge of pharma logistics and its profound impact on patients and healthcare providers worldwide."
Press Release Published by:
PMGroup Worldwide Ltd, 44 Maiden Lane, Covent Garden, London WC2E 7LN
FlyPharma Press Contact:
James Tansill
Marketing and Content Executive
jtansill@pmlive.com
+44 (0)20 7724 3456
About FlyPharma Conferences
FlyPharma Conferences are aimed at forward-thinking individuals and businesses who are looking to expand the potential of their pharma supply chains. These events offer an interactive platform to discuss current and future pharma and cargo supply chain challenges, including topics such as market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players.
FlyPharma Conferences are run by specialist pharmaceutical publisher Samedan Ltd, which produces a range of market-leading magazines for senior and middle-management professionals across the global pharma and life sciences sectors. In 2021, Samedan Ltd became part of PMGroup Worldwide Ltd and Datateam Media Group. The acquisition brings together three publishing powerhouses in the pharmaceutical and healthcare sector. As well as joining forces with established titles like PME, PharmaTimes and digital products PMLiVE and pharmatimes.com, PMGroup run a number of awards programmes which recognise best practice in the pharma and healthcare sectors. The union has allowed all brands to expand their readership and their live, virtual and hybrid events and award schemes.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Copenhagen Airports A/S, SAS Cargo and World Courier to Host FlyPharma 2026 in Copenhagen here
News-ID: 4401144 • Views: …
More Releases from Samedan Ltd
DSV - Global Transport and Logistics will be Gold Sponsors at FlyPharma Copenhag …
When supply chain performance directly impacts patient safety, compliance, and brand reputation, healthcare companies need a logistics partner they can rely on. At DSV, the purpose is to keep customers' supply chains flowing around a world in constant change.
With close to 150,000 employees in over 90 countries, DSV moves millions of shipments for their customers every year by air, sea, road, rail, and contract logistics solutions.
For pharmaceutical and…
Agenda Announced for FlyPharma Copenhagen 2026
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is excited to announce its agenda for FlyPharma Copenhagen 2026 is now live. Check out the full agenda here: https://flypharmaeurope.com.
Alongside host sponsors Copenhagen Airport, SAS Cargo, and Cencora World Courier, FlyPharma Copenhagen already has the largest number of confirmed exhibitors in FlyPharma history and is set to be the most expansive conference yet.
Taking place on 6-7…
FlyPharma 2025 Amsterdam officially announced as contracts are signed with host …
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, which will take place in Amsterdam from October 8-9, 2025. The FlyPharma Amsterdam 2025 conference will convene industry experts to explore the unique challenges and opportunities facing the region and beyond. In a first for FlyPharma, this year's event is supported by three host sponsors: Amsterdam Airport Schiphol, Air France…
FlyPharma 2024: An Event to Remember
FlyPharma Vienna 2024 has officially concluded! The landmark event successfully united industry professionals, expert speakers and delegates, from notable companies such as Sanofi, Takeda, Bayer, Amgen, Octapharma, Lufthansa, IATA, DHL, DoKaSch, Kühne + Nagel and more. Hosted in the historic city of Vienna, this year's conference highlighted actionable solutions and groundbreaking ideas aimed at advancing the future of pharma logistics and supply chains.
The event launched with hands-on workshops, including a…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…